Name of the Faculty: Dr. (Mrs.) M. S. Nagarsenker
Designation: Emeritus Professor
Email: mangal.nagarsenker@gmail.com
Teaching Fields : Pharmaceutics, Novel drug delivery systems, dispensing pharmacy
Educational Qualifications:
|
Sr no.
|
Degree
|
University
|
Year of Passing
|
|
1)
|
PhD (Tech.)
|
Mumbai University
|
1989
|
|
2)
|
M. Pharm
|
Mumbai University
|
1981
|
|
3)
|
B. Pharm
|
Mumbai University
|
1978
|
Awards and Fellowships:(ALL)
|
Sr no.
|
Award/Fellowship
|
Year of Receipt
|
|
1)
|
Prof M. L. Khorana best research paper award for paper:
Formulation and Evaluation of Long Circulating Liposomal Amphotericin B:
A Scinti-kinetic Study using Tc in BALB/C Mice, Indian journal of pharmaceutical sciences 2011;73(1):57-64
|
2013
|
|
2)
|
Association of Pharmaceutical Teachers of India (APTI) Dr. (Mrs.) Manjushree Pal Best Researcher National Award
|
2013
|
|
3)
|
Amrut Mody Research Fund, Distinguished Researcher National Award
|
2012
|
|
4)
|
Prof. (Mrs.) M. R. Baichwal Visiting fellow in Pharm Sci. and Technology for UICT
|
2005-2006
|
Recent Publications: (Best Five in last five years)
|
Sr no.
|
Paper Title(Best Five in last five years)
|
Jounal Details
|
|
1)
|
Role of Nanomedicine in Hepatic Targeting- Deciphering Strategies with
Molecular Insights and Preclinical Prospects
|
Drug Delivery Letters,2017
|
|
2)
|
Pulmonary delivery of synergistic combination of fluoroquinolone antibiotic
complemented with proteolytic enzyme: A novel antimicrobial and antibiofilm strategy
|
Nanomedicine: Nanotechnology, Biology and Medicine,2017
|
|
3)
|
Catanionic systems in nanotherapeutics–Biophysical aspects and novel trends in
drug delivery applications
|
Journal of Controlled Release,2017
|
|
4)
|
Surface-Modified Liposomal Formulation of Amphotericin B:
In vitro Evaluation of Potential against Visceral Leishmaniasis
|
AAPS PharmSciTech,2017.
|
|
5)
|
In Vitro and Ex Vivo Evaluations of Lipid Anti-Cancer Nanoformulations:
Insights and Assessment of Bioavailability Enhancement
|
AAPS PharmSciTech,2016
|
Recent Patents:(ALL)
|
Sr no.
|
Patent Title
|
Patent Number
|
|
1)
|
A process for preparing oral composition of ondansetron
|
206316
|
|
2)
|
Gastroretentive systems and novel pharmaceutical compositions thereof
|
234801
|
|
3)
|
Novel compositions for improved delivery of drugs with poor aqueous solubility
|
269000
|
|
4)
|
Pharmaceutical Composition Comprising Solid Dispersion of BCS Class II Drugs with Gelucires.
|
1874/MUM/2014
|
|
5)
|
“Apparatus for the determination of dissolution and permeation of drugs”
|
(201721019541)
|
Awards and Honours
|
Sr no.
|
Presentation Title(Best Five in last five years)
|
Conference Details
|
|
1)
|
Stearylated Arabinogalactan: Mitigating Challenges in Hepatic
Disorders Through a Targeted Approach
|
AAPS Annual Meeting and Exposition held in San Diego, CA, U.S.A 2017
|
|
2)
|
Novel Estradiol Loaded Cationic Polymeric Nanoparticles for Bone Specific Delivery
|
AAPS Annual Meeting and Exposition held in San Diego, CA, U.S.A 2017
|
|
3)
|
Novel osteotropic liposomes: Promising nanosystems in osteoporosis therapy
|
9th Annual conference on Clinical Pharmacology in Maternal and Child Care
organized by the South Asian Chapter of American College of Clinical Pharmacology, 2016
|
|
4)
|
Phospholipid Vesicular Systems for Enhanced Nelfinavir Mesylate Bioavailability
|
9th Annual conference on Clinical Pharmacology in Maternal and Child Care
organized by the South Asian Chapter of American College of Clinical Pharmacology, 2016
|
|
5)
|
Nelfinavir Mesylate nanoconstructs for improved oral delivery: In vitro
and In vivo proof of concept
|
9th Annual conference on Clinical Pharmacology in Maternal and Child Care
organized by the South Asian Chapter of American College of Clinical Pharmacology, 2016
|
Collaborations: (in current year)
|
Sr no.
|
Title
|
Industry/institute
|
|
1)
|
|
T. N. Medical College and BYL Nair Charitable Hospital, Mumbai
|
|
2)
|
|
Seth GS Medical College and KEM Hospital, Parel, Mumbai
|
|
3)
|
|
Babha Atomic Research Centre (BARC), Trombay, Mumbai
|
|
4)
|
|
Indian Institute of Chemical Technology (CSIR-IICT), Hyderabad
|
|
5)
|
|
Centre for drug research, University of Helsinki, Finland
|
|
6)
|
|
Department of pharmaceutical technology, F S University of Jena, Germany
|
Research Area and interest:
»
» Fabrication and characterization of nanocarriers like liposomes, lipid particulates, nanosuspensions,
Self nanoemulsifying drug delivery systems in the area of Oncology, pain management, antivirals.
» Design and development controlled release and targeted delivery systems.
»Investigations on three trademark systems LeciPlex®, Lecithmer® and GeluPearl®.
»Evaluation of role of excipients in design of dosage form.
»Delivery systems for nucleic acids for improved therapy.
Expertise and instrumental/research facilities you can provide to interested parties:
»
For solid dosage forms which include rapid mixer granulator, fluidized bed coater,
GMP model compression machine and dissolution test apparatus.
»
Go to TOP
Name of the Faculty: Dr. Rachna Kaul
Designation: Assistant Professor
Email: Rachna.kaul@bcp.edu.in, rachnakaul20@gmail.com
Teaching Fields : Biochemistry, Biotechnology
Educational Qualifications:
|
Sr no.
|
Degree
|
University
|
Year of Passing
|
|
1)
|
Ph. D (Molecular Medicine).
|
Jawaharlal Nehru University, New Delhi
|
2010
|
|
2)
|
M.Sc Biotechnology.
|
Panjab University, Chandigarh
|
1997
|
|
3)
|
B.Sc (Hons) Biochemistry
|
Delhi University
|
1995
|
Recent Publications: (Best Five in last five years)
|
Sr no.
|
Paper Title(Best Five in last five years)
|
Journal Details
|
|
1)
|
Human gene encoding hyaluronan binding protein 1 (HABP1/p32/gC1qR):
involvement in signaling cascade.
|
Nucleus (2017) doi:10.1007/s13237-017-0207-6.
|
|
2)
|
Role of PXR in hepatic cancer: Its influences on liver detoxification
capacity and cancer progression.
|
Plos One 2016 Oct 19;11(10) :e0164087. doi: 10.1371/journal.pone.0164087
|
|
3)
|
Inhibition of Mucin-Type O-Glycosylation through Metabolic Processing and
Incorporation of N-Thioglycolyl-d-galactosamine Peracetate (Ac5GalNTGc)
|
J Am Chem Soc.(2013)Sep 25;135(38):14189-97.doi: 10.1021/ja405189k
|
|
4)
|
Overexpression of hyaluronan binding protein 1 (HABP1/p32/gC1qR) in HepG2
cell leads to increased hyaluronan synthesis and cell proliferation by
upregulation of cyclin D1 in AKT-dependent pathway
|
J Biol Chem (2012) 28 (23): 19750-64
|
Awards and Honours
|
Sr no.
|
Presentation Title(Best Five in last five years)
|
Conference Details
|
|
1)
|
Functional Role of Hyaluronan binding protein1 (HABP1) in the regulation
of tumor progression by cancerous cells
|
HA 2013, June 2013, Oklahoma, USA
|
|
2)
|
Engineering of N-acetyl-D-galactosamine (GalNAc) on cell surface glycans
using small molecules modulates glycoforms of CD43
|
New Frontiers at the Interface of Immunity and Glycobiology, March 2011, Canada
|
|
3)
|
Metabolic engineering of carbohydrates on cell surface using small molecules:
Modulation of glycoforms of CD43 (leukosialin)
|
Indo-French Symposium on infectious diseases. New Delhi, December 2010
|
|
4)
|
Multifaceted regulation of hyaluronan binding protein1 (HABP1/gC1qR/p32) on
tumor progression and metastasis
|
8th International Conference on Hyaluronan (ISHAS), Kyoto, Japan, June 2010
|
Research Area and interest:
»
Teaching duties include basic and advanced biochemistry, biotechnology.
Research interests include cell and molecular biology.
Go to TOP